Profit slightly better than guidance given in late April. I'm happy. The outlook comment is the standard cut and paste job ....... blah blah, good growth, momentum, etc. No mention of fee reductions but they review that issue twice a year. Maybe late 2017 something will happen in that area. I'm still expecting EPS of $7-8 for FY 18 but only if no fee reductions in 2nd half.
- Forums
- ASX - By Stock
- AEF
- Ann: AEF Shareholder Presentation
Ann: AEF Shareholder Presentation, page-2
Featured News
Add AEF (ASX) to my watchlist
(20min delay)
|
|||||
Last
$4.85 |
Change
-0.070(1.42%) |
Mkt cap ! $483.8M |
Open | High | Low | Value | Volume |
$4.97 | $4.97 | $4.84 | $643.8K | 131.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1490 | $4.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.91 | 490 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3054 | 2.360 |
2 | 321 | 2.340 |
1 | 370 | 2.290 |
2 | 5353 | 2.260 |
1 | 9000 | 2.250 |
Price($) | Vol. | No. |
---|---|---|
2.380 | 8849 | 3 |
2.390 | 8260 | 1 |
2.400 | 4200 | 2 |
2.460 | 280 | 1 |
2.500 | 1500 | 1 |
Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
Featured News
AEF (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online